Agios Pharmaceuticals AGIO EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's EV / sales?
- Agios Pharmaceuticals (AGIO) reported EV / sales of 28.8× in Q1 2026.
- How has Agios Pharmaceuticals's EV / sales changed year-over-year?
- Agios Pharmaceuticals's EV / sales decreased by 35.4% year-over-year, from 44.6× to 28.8×.
- What is the long-term trend for Agios Pharmaceuticals's EV / sales?
- Over 4 years (2020 to 2025), Agios Pharmaceuticals's EV / sales has grown at a 25.5% compound annual growth rate (CAGR), from 11.5× to 28.5×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.